Literature DB >> 23217329

Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.

Sandrine Vuillaumier-Barrot1, Céline Bouchet-Séraphin, Malika Chelbi, Louise Devisme, Samuel Quentin, Steven Gazal, Annie Laquerrière, Catherine Fallet-Bianco, Philippe Loget, Sylvie Odent, Dominique Carles, Anne Bazin, Jacqueline Aziza, Alix Clemenson, Fabien Guimiot, Maryse Bonnière, Sophie Monnot, Christine Bole-Feysot, Jean-Pierre Bernard, Laurence Loeuillet, Marie Gonzales, Koryna Socha, Bernard Grandchamp, Tania Attié-Bitach, Férechté Encha-Razavi, Nathalie Seta.   

Abstract

Cobblestone lissencephaly is a peculiar brain malformation with characteristic radiological anomalies. It is defined as cortical dysplasia that results when neuroglial overmigration into the arachnoid space forms an extracortical layer that produces agyria and/or a "cobblestone" brain surface and ventricular enlargement. Cobblestone lissencephaly is pathognomonic of a continuum of autosomal-recessive diseases characterized by cerebral, ocular, and muscular deficits. These include Walker-Warburg syndrome, muscle-eye-brain disease, and Fukuyama muscular dystrophy. Mutations in POMT1, POMT2, POMGNT1, LARGE, FKTN, and FKRP identified these diseases as alpha-dystroglycanopathies. Our exhaustive screening of these six genes, in a cohort of 90 fetal cases, led to the identification of a mutation in only 53% of the families, suggesting that other genes might also be involved. We therefore decided to perform a genome-wide study in two multiplex families. This allowed us to identify two additional genes: TMEM5 and ISPD. Because TMEM has a glycosyltransferase domain and ISPD has an isoprenoid synthase domain characteristic of nucleotide diP-sugar transferases, these two proteins are thought to be involved in the glycosylation of dystroglycan. Further screening of 40 families with cobblestone lissencephaly identified nonsense and frameshift mutations in another four unrelated cases for each gene, increasing the mutational rate to 64% in our cohort. All these cases displayed a severe phenotype of cobblestone lissencephaly A. TMEM5 mutations were frequently associated with gonadal dysgenesis and neural tube defects, and ISPD mutations were frequently associated with brain vascular anomalies.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217329      PMCID: PMC3516603          DOI: 10.1016/j.ajhg.2012.10.009

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  51 in total

1.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).

Authors:  E Schollen; S Kjaergaard; E Legius; M Schwartz; G Matthijs
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

2.  Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathies.

Authors:  S Vuillaumier-Barrot; C Bouchet-Seraphin; M Chelbi; A Eude-Caye; E Charluteau; C Besson; S Quentin; L Devisme; C Le Bizec; P Landrieu; A Goldenberg; K Maincent; P Loget; O Boute; B Gilbert-Dussardier; F Encha-Razavi; M Gonzales; B Grandchamp; N Seta
Journal:  Neuromuscul Disord       Date:  2011-07-02       Impact factor: 4.296

3.  Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.

Authors:  P K Cheung; C McCormick; B E Crawford; J D Esko; F Tufaro; G Duncan
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

4.  Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis.

Authors:  S B Richard; M E Bowman; W Kwiatkowski; I Kang; C Chow; A M Lillo; D E Cane; J P Noel
Journal:  Nat Struct Biol       Date:  2001-07

5.  Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O.

Authors:  Madalina Raducu; Jonathan Baets; Oihane Fano; Rudy Van Coster; Jesús Cruces
Journal:  Eur J Hum Genet       Date:  2012-03-14       Impact factor: 4.246

6.  Heparan/chondroitin sulfate biosynthesis. Structure and mechanism of human glucuronyltransferase I.

Authors:  L C Pedersen; K Tsuchida; H Kitagawa; K Sugahara; T A Darden; M Negishi
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Authors:  Tobias Willer; Hane Lee; Mark Lommel; Takako Yoshida-Moriguchi; Daniel Beltran Valero de Bernabe; David Venzke; Sebahattin Cirak; Harry Schachter; Jiri Vajsar; Thomas Voit; Francesco Muntoni; Andrea S Loder; William B Dobyns; Thomas L Winder; Sabine Strahl; Katherine D Mathews; Stanley F Nelson; Steven A Moore; Kevin P Campbell
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

8.  Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation.

Authors:  Dirk J Lefeber; Arjan P M de Brouwer; Eva Morava; Moniek Riemersma; Janneke H M Schuurs-Hoeijmakers; Birgit Absmanner; Kiek Verrijp; Willem M R van den Akker; Karin Huijben; Gerry Steenbergen; Jeroen van Reeuwijk; Adam Jozwiak; Nili Zucker; Avraham Lorber; Martin Lammens; Carlos Knopf; Hans van Bokhoven; Stephanie Grünewald; Ludwig Lehle; Livia Kapusta; Hanna Mandel; Ron A Wevers
Journal:  PLoS Genet       Date:  2011-12-29       Impact factor: 5.917

9.  Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.

Authors:  Tony Roscioli; Erik-Jan Kamsteeg; Karen Buysse; Isabelle Maystadt; Jeroen van Reeuwijk; Christa van den Elzen; Ellen van Beusekom; Moniek Riemersma; Rolph Pfundt; Lisenka E L M Vissers; Margit Schraders; Umut Altunoglu; Michael F Buckley; Han G Brunner; Bernard Grisart; Huiqing Zhou; Joris A Veltman; Christian Gilissen; Grazia M S Mancini; Paul Delrée; Michèl A Willemsen; Danijela Petković Ramadža; David Chitayat; Christopher Bennett; Eamonn Sheridan; Els A J Peeters; Gita M B Tan-Sindhunata; Christine E de Die-Smulders; Koenraad Devriendt; Hülya Kayserili; Osama Abd El-Fattah El-Hashash; Derek L Stemple; Dirk J Lefeber; Yung-Yao Lin; Hans van Bokhoven
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

Review 10.  A developmental and genetic classification for malformations of cortical development: update 2012.

Authors:  A James Barkovich; Renzo Guerrini; Ruben I Kuzniecky; Graeme D Jackson; William B Dobyns
Journal:  Brain       Date:  2012-03-16       Impact factor: 13.501

View more
  59 in total

Review 1.  Developmental biology of the meninges.

Authors:  Krishnakali Dasgupta; Juhee Jeong
Journal:  Genesis       Date:  2019-03-13       Impact factor: 2.487

Review 2.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

3.  The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.

Authors:  Hiroshi Manya; Yoshiki Yamaguchi; Motoi Kanagawa; Kazuhiro Kobayashi; Michiko Tajiri; Keiko Akasaka-Manya; Hiroko Kawakami; Mamoru Mizuno; Yoshinao Wada; Tatsushi Toda; Tamao Endo
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

4.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

Review 5.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

6.  A glycogene mutation map for discovery of diseases of glycosylation.

Authors:  Lars Hansen; Allan Lind-Thomsen; Hiren J Joshi; Nis Borbye Pedersen; Christian Theil Have; Yun Kong; Shengjun Wang; Thomas Sparso; Niels Grarup; Malene Bech Vester-Christensen; Katrine Schjoldager; Hudson H Freeze; Torben Hansen; Oluf Pedersen; Bernard Henrissat; Ulla Mandel; Henrik Clausen; Hans H Wandall; Eric P Bennett
Journal:  Glycobiology       Date:  2014-09-28       Impact factor: 4.313

7.  Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Peter B Kang; Leslie Morrison; Susan T Iannaccone; Robert J Graham; Carsten G Bönnemann; Anne Rutkowski; Joseph Hornyak; Ching H Wang; Kathryn North; Maryam Oskoui; Thomas S D Getchius; Julie A Cox; Erin E Hagen; Gary Gronseth; Robert C Griggs
Journal:  Neurology       Date:  2015-03-31       Impact factor: 9.910

8.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Authors:  Elizabeth Stevens; Keren J Carss; Sebahattin Cirak; A Reghan Foley; Silvia Torelli; Tobias Willer; Dimira E Tambunan; Shu Yau; Lina Brodd; Caroline A Sewry; Lucy Feng; Goknur Haliloglu; Diclehan Orhan; William B Dobyns; Gregory M Enns; Melanie Manning; Amanda Krause; Mustafa A Salih; Christopher A Walsh; Matthew Hurles; Kevin P Campbell; M Chiara Manzini; Derek Stemple; Yung-Yao Lin; Francesco Muntoni
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

9.  Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.

Authors:  Haipo Yang; Hiroshi Manya; Kazuhiro Kobayashi; Hui Jiao; Xiaona Fu; Jiangxi Xiao; Xiaoqing Li; Jingmin Wang; Yuwu Jiang; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-05-19       Impact factor: 3.172

10.  Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.

Authors:  Farid Radmanesh; Ahmet Okay Caglayan; Jennifer L Silhavy; Cahide Yilmaz; Vincent Cantagrel; Tarek Omar; Başak Rosti; Hande Kaymakcalan; Stacey Gabriel; Mingfeng Li; Nenad Sestan; Kaya Bilguvar; William B Dobyns; Maha S Zaki; Murat Gunel; Joseph G Gleeson
Journal:  Am J Hum Genet       Date:  2013-03-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.